Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!

How has the migraine treatment market grown in recent years?

Over the past few years, there has been notable growth in the market of migraine treatment. The market value is predicted to rise from $3.18 billion in 2024 to $3.48 billion in 2025, indicating a compound annual growth rate (CAGR) of 9.4%. This surge during the historical period can be linked to factors such as a higher frequency of migraines, increased spending on healthcare, enhancements in the formulations of current drugs, expansion in clinical research, and the advent of new treatments.

How is the migraine treatment market size expected to evolve during the forecast period?

In the coming years, the migraine treatment market is poised for rapid expansion. The market is set to reach $5.32 billion in 2029, with a compound annual growth rate (CAGR) of 11.2%. This growth in the projected period can be credited to increasing awareness and education about migraines, the introduction of monoclonal antibodies, heightened focus on pediatric migraines, the broadening scope of non-drug interventions, and global initiatives aimed at migraine research. Prominent trends during the forecast period encompass innovations in therapeutic methods, applications of wearable devices and digital therapeutics, adoption of telemedicine and remote consultations, patient-oriented care models, the expansion of the generic drug market, and the emergence of oral CGRP inhibitors.

Get your migraine treatment market report here!

https://www.thebusinessresearchcompany.com/report/migraine-treatment-global-market-report

Which key drivers are propelling the migraine treatment market’s growth?

The expansive use of screens is predicted to boost the development of the migraine treatment market. The term “screen exposure” pertains to the duration an individual spends gazing at digital screens, such as those found on smartphones, computers, tablets, and televisions. The escalation in remote work, digital learning, electronic amusement, and the ever-growing need for technology in social exchanges are all contributors to the excessive use of screens. Migraine management encompasses symptomatic relief from migraines that may be induced or exacerbated by extended screen usage, through methods like medication, lifestyle changes, and employing ergonomic techniques to reduce discomfort and avert migraines occurrences. For instance, as pointed out by a health entity under the UK Parliament, the House of Commons Committee, the screen-time of children amplified by 52% in 2022 compared to the previous year. Nearly a quarter of children and young adults displayed a pattern of smartphone usage that resembled behavioral addiction. Consequently, the surge in screen time is influencing the expansion of the migraine treatment market.

What are the market segments in the migraine treatment industry?

The migraine treatment market covered in this report is segmented –

1) By Types: Episodic, Migraine With Aura, Chronic, Other Types

2) By Treatment: Acute Or Abortive Treatment, Preventive Or prophylactic Treatment, Non-Pharmacological Therapies And Devices

3) By End-User: Hospitals, Clinics, Homecare, Other End-users

Subsegments:

1) By Episodic: Frequent Episodic Migraine, Infrequent Episodic Migraine

2) By Migraine With Aura: Visual Aura, Sensory Aura, Speech Or Language Aura

3) By Chronic: Chronic Migraine Without Aura, Chronic Migraine With Aura

4) By Other Types: Hemiplegic Migraine, Retinal Migraine, Menstrual Migraine, Other Specific Types

Get your free sample now – explore exclusive market insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=8126&type=smp

Which leading companies are shaping the growth of the migraine treatment market?

Major companies operating in the migraine treatment market are Pfizer Inc., Eli Lilly and Company, Amgen Inc., GlaxoSmithKline PLC, Novartis AG, Bayer AG, Allergan PLC, Abbott Laboratories, Allodynic Therapeutics LLC, AOBiome LLC, AstraZeneca PLC, Bausch Health Companies Inc., Boehringer Ingelheim International GmbH, Dr. Reddy’s Laboratories Limited, Impel Pharmaceuticals Inc., AbbVie Inc., Alder BioPharmaceuticals Inc., Astellas Pharma Inc., Biohaven Pharmaceutical Holding Company Ltd., Bristol-Myers Squibb Company, Daiichi Sankyo Company Limited, Eisai Co. Ltd., Endo International PLC, Impax Laboratories Inc., Johnson & Johnson Inc., Lannett Company Inc., Lupin Limited, Merck & Co. Inc., Mylan N.V.

What key trends are currently impacting the migraine treatment market’s development?

The migraine treatment market is currently seeing a trend of product innovations. Many leading firms in the industry are utilizing innovations like liquid formulations to maintain their competitive edge. For instance, BioDelivery Sciences International (BDSI), a pharmaceutical company based in the US, launched Elyxyb (celecoxib oral solution) in January 2022. This new product, intended for the acute treatment of migraines in adults irrespective of aura experience, boasts a liquid formulation that is more rapidly absorbed in the small intestine, offering quicker relief than conventional tablets. This is particularly advantageous for patients who suffer from nausea or vomiting linked to migraines, as it removes the necessity for a pill to dissolve. As the single and only FDA-approved ready-to-use oral solution for migraines, Elyxyb presents a more palatable and effective treatment method for dealing with the sudden, severe pain that migraines bring.

Unlock exclusive market insights – purchase your research report now for a swift delivery!

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=8126

Which geographic areas are influencing the growth of the migraine treatment market?

North America was the largest region in the migraine treatment market in 2024. The regions covered in the migraine treatment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Browse Through More Similar Reports By The Business Research Company:

Virology Specimen Collection Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/virology-specimen-collection-global-market-report

Cough And Cold Preparations Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/cough-and-cold-preparations-global-market-report

Mucosal Atomization Devices Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/mucosal-atomization-devices-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at [email protected]

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on: